Patent Yard Sign in
Canadian application, no grantCanada

Targeted ligands

CA 2402930 A1 · Owner: Herman, William · Inventors: Herman, William

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The invention contemplates a composition containing a multispecific ligand containing at least a tirst, ligand binding moiety and a second ligand binding moiety. The first ligand binding moiety specifically, binds with a pre-selected first affinity to at least a first ligand. The first ligand has a first biodistribution. The second ligand binding moiety specifically binds with a pre-selected affinity to at least a second ligand. The second ligand has a second biodistribution. The aftinity of tirst and second ligand binding moieties are, selected to bias the biodistribution of the multispecitic ligand in favour of a selected location of one or both, of the ligands.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed September 19, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 19, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 19, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledSeptember 19, 2002
GrantedNo grant recorded
Term endedSeptember 19, 2022
Patent numberCA 2402930 A1
Classification (IPC)A61K47/48 +2 more

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedSep 19, 2002Term endedSep 19, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.